Total Payments
$2,250
2024 Payments
$893.47
Companies
20
Transactions
78
Medicare Patients
541
Medicare Billing
$66,219
Payment Breakdown by Category
Food & Beverage$2,201 (97.8%)
Education$48.84 (2.2%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,201 | 77 | 97.8% |
| Education | $48.84 | 1 | 2.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ITI, Inc. | $353.66 | 15 | $0 (2023) |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $344.61 | 12 | $0 (2024) |
| Axsome Therapeutics, Inc. | $257.39 | 6 | $0 (2024) |
| ABBVIE INC. | $217.92 | 7 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $214.53 | 4 | $0 (2023) |
| Corium, LLC | $151.18 | 3 | $0 (2023) |
| IDORSIA PHARMACEUTICALS US INC | $141.07 | 4 | $0 (2023) |
| Braeburn Inc. | $121.42 | 2 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $104.79 | 6 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $77.18 | 4 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $893.47 | 32 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) ($344.61) |
| 2023 | $937.08 | 35 | ABBVIE INC. ($217.92) |
| 2022 | $419.71 | 11 | ITI, Inc. ($207.63) |
All Payment Transactions
78 individual payment records from CMS Open Payments — Page 3 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/11/2023 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $16.54 | General |
| Category: INSOMNIA | ||||||
| 05/11/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $10.81 | General |
| Category: NEUROSCIENCE | ||||||
| 05/04/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $64.07 | General |
| Category: NEUROSCIENCE | ||||||
| 05/03/2023 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $23.19 | General |
| Category: Neuroscience | ||||||
| 05/03/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $4.54 | General |
| Category: NEUROSCIENCE | ||||||
| 04/20/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $14.92 | General |
| Category: PSYCHIATRY | ||||||
| 04/17/2023 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $16.84 | General |
| Category: NEUROSCIENCE | ||||||
| 04/07/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $25.16 | General |
| Category: NEUROSCIENCE | ||||||
| 03/07/2023 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $15.30 | General |
| Category: NEUROSCIENCE | ||||||
| 02/23/2023 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $16.82 | General |
| Category: PSYCHIATRY | ||||||
| 02/02/2023 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $84.72 | General |
| Category: NEUROSCIENCE | ||||||
| 01/27/2023 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $17.23 | General |
| Category: Psychology/Psychiatric | ||||||
| 01/19/2023 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $14.44 | General |
| Category: NEUROSCIENCE | ||||||
| 01/18/2023 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $12.65 | General |
| Category: PSYCHIATRY | ||||||
| 01/18/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.19 | General |
| Category: NEUROSCIENCE | ||||||
| 01/13/2023 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $112.90 | General |
| Category: INSOMNIA | ||||||
| 01/05/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.43 | General |
| Category: NEUROSCIENCE | ||||||
| 12/13/2022 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $91.75 | General |
| Category: PSYCHIATRY | ||||||
| 11/30/2022 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $17.50 | General |
| Category: PSYCHIATRY | ||||||
| 11/02/2022 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $19.18 | General |
| Category: PSYCHIATRY | ||||||
| 10/07/2022 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $14.39 | General |
| Category: PSYCHIATRY | ||||||
| 09/27/2022 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $66.12 | General |
| Category: Neuroscience | ||||||
| 09/13/2022 | Corium, LLC | AZSTARYS (Drug) | Food and Beverage | In-kind items and services | $91.65 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 09/09/2022 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), REXULTI | Food and Beverage | In-kind items and services | $16.39 | General |
| Category: PSYCHIATRY | ||||||
| 09/01/2022 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $41.18 | General |
| Category: PSYCHIATRY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 30 | 46 | $9,265 | $3,198 |
| 2022 | 2 | 111 | 206 | $66,804 | $9,729 |
| 2021 | 4 | 400 | 734 | $227,032 | $53,292 |
Total Patients
541
Total Services
986
Medicare Billing
$66,219
Procedure Codes
11
All Medicare Procedures & Services
11 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2023 | 19 | 19 | $5,846 | $2,106 | 36.0% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2023 | 11 | 27 | $3,419 | $1,092 | 32.0% |
| 99309 | Follow-up nursing facility visit per day, typically 25 minutes | Facility | 2022 | 73 | 150 | $47,850 | $5,894 | 12.3% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2022 | 18 | 18 | $6,832 | $2,141 | 31.3% |
| 99309 | Follow-up nursing facility visit per day, typically 25 minutes | Office | 2022 | 20 | 38 | $12,122 | $1,693 | 14.0% |
| 99309 | Subsequent nursing facility visit, typically 25 minutes per day | Facility | 2021 | 152 | 426 | $125,659 | $24,236 | 19.3% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Facility | 2021 | 136 | 138 | $58,056 | $15,734 | 27.1% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2021 | 61 | 61 | $17,385 | $7,422 | 42.7% |
| 99309 | Subsequent nursing facility visit, typically 25 minutes per day | Office | 2021 | 26 | 82 | $23,688 | $4,698 | 19.8% |
| G0425 | Telehealth consultation, emergency department or initial inpatient, typically 30 minutes communicating with the patient via telehealth | Office | 2021 | 13 | 13 | $1,577 | $846.98 | 53.7% |
| G0406 | Follow-up inpatient consultation, limited, physicians typically spend 15 minutes communicating with the patient via telehealth | Office | 2021 | 12 | 14 | $667.30 | $355.32 | 53.2% |
About Kizzie Houston
Kizzie Houston is a Psychiatric/Mental Health healthcare provider based in Little Rock, Arkansas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/11/2021. The National Provider Identifier (NPI) number assigned to this provider is 1225620149.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Kizzie Houston has received a total of $2,250 in payments from pharmaceutical and medical device companies, with $893.47 received in 2024. These payments were reported across 78 transactions from 20 companies. The most common payment nature is "Food and Beverage" ($2,201).
As a Medicare-enrolled provider, Houston has provided services to 541 Medicare beneficiaries, totaling 986 services with total Medicare billing of $66,219. Data is available for 3 years (2021–2023), covering 11 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatric/Mental Health
- Location Little Rock, AR
- Active Since 02/11/2021
- Last Updated 01/23/2026
- Taxonomy Code 363LP0808X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1225620149
Products in Payments
- CAPLYTA (Drug) $698.27
- Auvelity (Drug) $257.39
- SPRAVATO (Drug) $165.84
- QUVIVIQ (Drug) $141.07
- VRAYLAR (Drug) $133.20
- BRIXADI (Drug) $121.42
- AZSTARYS (Drug) $91.65
- REXULTI (Drug) $88.40
- QULIPTA (Drug) $84.72
- INGREZZA (Drug) $77.18
- Azstarys (Drug) $59.53
- INVEGA SUSTENNA (Drug) $48.69
- TRINTELLIX (Drug) $46.58
- HETLIOZ (Drug) $29.30
- DOVATO (Drug) $28.13
- SUBLOCADE (Drug) $24.71
- APRETUDE (Biological) $23.65
- Cologuard Collection Kit (Device) $22.57
- Qelbree (Drug) $19.78
- Vivitrol (Drug) $19.25
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatric/Mental Health Doctors in Little Rock
Cara Meckfessel, Aprn, APRN
Psychiatric/Mental Health — Payments: $7,199
Psychiatric/Mental Health $7,199
Michelle Head
Psychiatric/Mental Health — Payments: $5,551
Psychiatric/Mental Health $5,551
Sara Jones, Phd, Aprn, Pmhnp-Bc, PHD, APRN, PMHNP-BC
Psychiatric/Mental Health — Payments: $4,663
Psychiatric/Mental Health $4,663
Chloe Ward, Aprn, APRN
Psychiatric/Mental Health — Payments: $4,251
Psychiatric/Mental Health $4,251
Jennifer Rawls, Aprn, APRN
Psychiatric/Mental Health — Payments: $3,031
Psychiatric/Mental Health $3,031
Ashley Taylor, Pmhnp, PMHNP
Psychiatric/Mental Health — Payments: $2,381
Psychiatric/Mental Health $2,381